Month: February 2020

Isoray Announces Second Quarter Fiscal 2020 Financial Results

Isoray Announces Second Quarter Fiscal 2020 Financial Results

Revenue for the second quarter of fiscal 2020 grew 16% to $2.21 million versus $1.90 million in the prior year comparable period.

Isoray Collaborates with MIM Software to Deliver an Advanced Treatment Solution for Recurrent Head and Neck Cancers

Isoray Collaborates with MIM Software to Deliver an Advanced Treatment Solution for Recurrent Head and Neck Cancers

Bringing together Isoray’s Cesium Blu brachytherapy seeds in mesh with MIM Software’s powerful brachytherapy treatment planning software provides physicians with all the anatomical information they need to effectively place the Cesium Blu seeds exactly where they are needed to treat the patient’s cancer.

Perspective Therapeutics
Linkedin-in Youtube Vimeo
Perspective Therapeutics
Linkedin-in Youtube Vimeo

Company

Brachytherapy

Theranostics

Newsletter

Want to keep up-to-date on news and information?

Sign up
Sign up

Company

Newsletter

Want to keep up-to-date on news and information?

Sign up
Sign up

©2023. All rights reserved. Terms & Privacy | Privacy Policy

Scroll to top